Corbus Pharmaceuticals Holdings, Inc.
CRBPHealthcare|Biotechnology|US
$3.07
+0.21 (+7.34%)
DCF Value
$1.97
Tangible Book / Share
$5.27
Cash / Share
$6.08
Ownership Breakdown
72.9%
Float
19.3M
Shares Outstanding
14.1M
Float Shares
Major Holders (24)
Combined: 122.8%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Bihua Chen | HC, IN | 12.82% | 2,375,000 | Nov 14, 2025 | 13D/G |
| Rajeev Shah | HC, IN | 9.90% | 1,914,788 | Sep 30, 2026 | 13D/G |
| RA Capital Management, L.P. | IA, PN | 9.90% | 1,914,788 | Sep 30, 2026 | 13D/G |
| Peter Kolchinsky | HC, IN | 9.90% | 1,914,788 | Sep 30, 2026 | 13D/G |
| RA Capital Healthcare Fund, L.P. | Partnership | 9.90% | 1,914,788 | Sep 30, 2026 | 13D/G |
| Cormorant Asset Management, LP | IA, PN | 7.76% | 1,500,000 | Nov 2, 2026 | 13D/G |
| Chen Bihua | HC, IN | 7.76% | 1,500,000 | Nov 2, 2026 | 13D/G |
| BlackRock, Inc. | Holding company | 5.90% | 1,093,434 | Jul 27, 2026 | 13D/G |
| OrbiMed Capital LLC | Investment adviser | 5.90% | 718,200 | Feb 14, 2025 | 13D/G |
| Kenneth Griffin | HC, IN | 5.30% | 980,610 | Nov 12, 2025 | 13D/G |
| The Vanguard Group | Investment adviser | 4.89% | 599,495 | Jul 29, 2025 | 13D/G |
| Citadel Advisors Holdings LP | HC, PN | 4.70% | 873,313 | Nov 12, 2025 | 13D/G |
| Citadel Advisors LLC | IA, HC, OO | 4.70% | 873,313 | Nov 12, 2025 | 13D/G |
| Citadel GP LLC | HC, OO | 4.70% | 873,313 | Nov 12, 2025 | 13D/G |
| Robert Atchinson | HC, IN | 4.39% | 528,937 | Nov 12, 2024 | 13D/G |
| Phillip Gross | HC, IN | 4.39% | 528,937 | Nov 12, 2024 | 13D/G |
| Adage Capital Management, L.P. | IA, PN | 4.39% | 528,937 | Nov 12, 2024 | 13D/G |
| OrbiMed Advisors LLC | Investment adviser | 3.70% | 454,087 | Feb 14, 2025 | 13D/G |
| Citadel Securities LLC | BD, OO | 0.60% | 107,297 | Nov 12, 2025 | 13D/G |
| Citadel Securities Group LP | HC, PN | 0.60% | 107,297 | Nov 12, 2025 | 13D/G |
| Citadel Securities GP LLC | HC, OO | 0.60% | 107,297 | Nov 12, 2025 | 13D/G |
| Anup Arora | HC, IN | 0.02% | 2,873 | Nov 14, 2024 | 13D/G |
| Parag Shah | HC, IN | 0.02% | 2,873 | Nov 14, 2024 | 13D/G |
| K2 HealthVentures Equity Trust LLC | Other | 0.02% | 2,873 | Nov 14, 2024 | 13D/G |
Insider Trades (100)
Last 4 quarters: 1,210,332 acquired · 184,831 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Cormorant Asset Management, LP | other: Former 10% Owner | Oct 29, 2026 | SELL | 425,000 | $4.10 | $1.7M | Form 4 |
| Ben Yong | director | Sep 14, 2026 | SELL | 2,000 | $7.84 | $15.7K | Form 4 |
| Nicacio Leonardo Viana | Chief Medical Officer | Aug 16, 2026 | AWARD | 191,676 | $10.09 | $1.9M | Form 4 |
| Nicacio Leonardo Viana | Chief Medical Officer | Aug 16, 2026 | AWARD | 58,333 | — | — | Form 4 |
| Saxena Nishant C | Chief Business Officer | Aug 11, 2026 | BUY | 2,600 | $9.63 | $25.0K | Form 4 |
| Cohen Yuval | director, officer: Chief Executive Officer | Aug 7, 2026 | SELL | 17,000 | $10.08 | $171.4K | Form 4 |
| Moran Sean F. | Chief Financial Officer | Aug 7, 2026 | SELL | 12,000 | $10.08 | $121.0K | Form 4 |
| Nicacio Leonardo Viana | Aug 3, 2026 | OTHER | 0 | — | — | Form 4 | |
| Kung Winston | director | Jun 10, 2026 | SELL | 2,026 | $7.91 | $16.0K | Form 4 |
| Altmeyer Anne | director | Jun 10, 2026 | SELL | 2,412 | $7.91 | $19.1K | Form 4 |
| Jenkins John Kenneth | director | Jun 10, 2026 | SELL | 4,800 | $7.91 | $38.0K | Form 4 |
| Saxena Nishant C | Chief Business Officer | Jun 3, 2026 | BUY | 9,000 | $7.58 | $68.2K | Form 4 |
| Saxena Nishant C | Chief Business Officer | Jun 2, 2026 | BUY | 4,500 | $7.33 | $33.0K | Form 4 |
| Saxena Nishant C | Chief Business Officer | May 21, 2026 | AWARD | 192,300 | $11.51 | $2.2M | Form 4 |
| Saxena Nishant C | Chief Business Officer | May 21, 2026 | AWARD | 58,300 | — | — | Form 4 |
| Saxena Nishant C | Chief Business Officer | May 21, 2026 | OTHER | 0 | — | — | Form 4 |
| Kung Winston | director | May 19, 2026 | AWARD | 3,800 | — | — | Form 4 |
| Kung Winston | director | May 19, 2026 | AWARD | 12,300 | $9.15 | $112.5K | Form 4 |
| Jacques Rachelle Suzanne | director | May 19, 2026 | AWARD | 12,300 | $9.15 | $112.5K | Form 4 |
| Jacques Rachelle Suzanne | director | May 19, 2026 | AWARD | 3,800 | — | — | Form 4 |
| Jenkins John Kenneth | director | May 19, 2026 | AWARD | 12,300 | $9.15 | $112.5K | Form 4 |
| Jenkins John Kenneth | director | May 19, 2026 | AWARD | 3,800 | — | — | Form 4 |
| Altmeyer Anne | director | May 19, 2026 | AWARD | 12,300 | $9.15 | $112.5K | Form 4 |
| Altmeyer Anne | director | May 19, 2026 | AWARD | 3,800 | — | — | Form 4 |
| Ben Yong | director | May 19, 2026 | AWARD | 12,300 | $9.15 | $112.5K | Form 4 |
| Ben Yong | director | May 19, 2026 | AWARD | 3,800 | — | — | Form 4 |
| Pfeiffenberger Brent | director | May 19, 2026 | AWARD | 24,700 | $9.15 | $226.0K | Form 4 |
| Pfeiffenberger Brent | director | May 19, 2026 | AWARD | 7,500 | — | — | Form 4 |
| Pfeiffenberger Brent | May 13, 2026 | OTHER | 0 | — | — | Form 4 | |
| Smethurst Dominic | Chief Medical Officer | Mar 2, 2026 | SELL | 6,097 | $8.30 | $50.6K | Form 4 |
| Hodgson Ian | Chief Operating Officer | Feb 17, 2026 | SELL | 847 | $7.38 | $6.3K | Form 4 |
| Moran Sean F. | Chief Financial Officer | Feb 13, 2026 | SELL | 4,701 | $7.78 | $36.6K | Form 4 |
| Cohen Yuval | director, officer: Chief Executive Officer | Feb 13, 2026 | SELL | 13,871 | $7.78 | $108.0K | Form 4 |
| Smethurst Dominic | Chief Medical Officer | Feb 3, 2026 | SELL | 3,285 | $8.09 | $26.6K | Form 4 |
| Hodgson Ian | Chief Operating Officer | Feb 3, 2026 | SELL | 2,415 | $8.09 | $19.5K | Form 4 |
| Smethurst Dominic | Chief Medical Officer | Jan 14, 2026 | AWARD | 28,365 | — | — | Form 4 |
| Smethurst Dominic | Chief Medical Officer | Jan 14, 2026 | AWARD | 85,095 | $8.26 | $702.9K | Form 4 |
| Moran Sean F. | Chief Financial Officer | Jan 14, 2026 | AWARD | 28,082 | — | — | Form 4 |
| Moran Sean F. | Chief Financial Officer | Jan 14, 2026 | AWARD | 84,247 | $8.26 | $695.9K | Form 4 |
| Cohen Yuval | director, officer: Chief Executive Officer | Jan 14, 2026 | AWARD | 50,000 | — | — | Form 4 |
| Cohen Yuval | director, officer: Chief Executive Officer | Jan 14, 2026 | AWARD | 150,000 | $8.26 | $1.2M | Form 4 |
| Hodgson Ian | Chief Operating Officer | Jan 14, 2026 | AWARD | 85,095 | $8.26 | $702.9K | Form 4 |
| Hodgson Ian | Chief Operating Officer | Jan 14, 2026 | AWARD | 28,365 | — | — | Form 4 |
| Cormorant Asset Management, LP | 10 percent owner | Dec 11, 2025 | SELL | 30,029 | $11.46 | $344.0K | Form 4 |
| Cohen Yuval | director, officer: Chief Executive Officer | Oct 24, 2025 | OPTION EX. | 18,660 | $4.26 | $79.5K | Form 4 |
| Cohen Yuval | director, officer: Chief Executive Officer | Oct 27, 2025 | OPTION EX. | 8,973 | $4.26 | $38.2K | Form 4 |
| Cohen Yuval | director, officer: Chief Executive Officer | Oct 27, 2025 | SELL | 8,973 | $17.14 | $153.8K | Form 4 |
| Cohen Yuval | director, officer: Chief Executive Officer | Oct 24, 2025 | SELL | 18,660 | $17.01 | $317.4K | Form 4 |
| Cohen Yuval | director, officer: Chief Executive Officer | Oct 24, 2025 | OPTION EX. | 18,660 | $4.26 | $79.5K | Form 4 |
| Cohen Yuval | director, officer: Chief Executive Officer | Oct 27, 2025 | OPTION EX. | 8,973 | $4.26 | $38.2K | Form 4 |
| Moran Sean F. | Chief Financial Officer | Oct 24, 2025 | OPTION EX. | 12,981 | $4.26 | $55.3K | Form 4 |
| Moran Sean F. | Chief Financial Officer | Oct 24, 2025 | SELL | 12,981 | $17.02 | $220.9K | Form 4 |
| Moran Sean F. | Chief Financial Officer | Oct 24, 2025 | OPTION EX. | 12,981 | $4.26 | $55.3K | Form 4 |
| Altmeyer Anne | director | Oct 20, 2025 | OPTION EX. | 1,060 | $4.80 | $5.1K | Form 4 |
| Altmeyer Anne | director | Oct 20, 2025 | SELL | 1,060 | $20.50 | $21.7K | Form 4 |
| Altmeyer Anne | director | Oct 20, 2025 | OPTION EX. | 1,060 | $4.80 | $5.1K | Form 4 |
| Kung Winston | director | May 30, 2025 | AWARD | 16,000 | $7.42 | $118.7K | Form 4 |
| Kung Winston | director | May 30, 2025 | AWARD | 4,800 | — | — | Form 4 |
| Jenkins John Kenneth | director | May 30, 2025 | AWARD | 16,000 | $7.42 | $118.7K | Form 4 |
| Jenkins John Kenneth | director | May 30, 2025 | AWARD | 4,800 | — | — | Form 4 |
| Jenkins John Kenneth | director | May 30, 2025 | SELL | 2,783 | $7.35 | $20.5K | Form 4 |
| Ben Yong | director | May 30, 2025 | AWARD | 16,000 | $7.42 | $118.7K | Form 4 |
| Ben Yong | director | May 30, 2025 | AWARD | 4,800 | — | — | Form 4 |
| Altmeyer Anne | director | May 30, 2025 | AWARD | 16,000 | $7.42 | $118.7K | Form 4 |
| Altmeyer Anne | director | May 30, 2025 | AWARD | 4,800 | — | — | Form 4 |
| Altmeyer Anne | director | May 30, 2025 | SELL | 1,392 | $7.25 | $10.1K | Form 4 |
| HOLMER ALAN F | director | May 30, 2025 | AWARD | 16,000 | $7.42 | $118.7K | Form 4 |
| HOLMER ALAN F | director | May 30, 2025 | AWARD | 4,800 | — | — | Form 4 |
| Jacques Rachelle Suzanne | director | May 30, 2025 | AWARD | 16,000 | $7.42 | $118.7K | Form 4 |
| Jacques Rachelle Suzanne | director | May 30, 2025 | AWARD | 4,800 | — | — | Form 4 |
| Hodgson Ian | Chief Operating Officer | Mar 13, 2025 | OTHER | 0 | — | — | Form 4 |
| Hodgson Ian | Chief Operating Officer | Mar 13, 2025 | OTHER | 0 | — | — | Form 4 |
| Hodgson Ian | Chief Operating Officer | Mar 13, 2025 | OTHER | 1,985 | $4.26 | $8.5K | Form 4 |
| Hodgson Ian | Chief Operating Officer | Mar 13, 2025 | OTHER | 60,000 | $9.79 | $587.4K | Form 4 |
| Hodgson Ian | Chief Operating Officer | Mar 13, 2025 | OTHER | 5,000 | $23.10 | $115.5K | Form 4 |
| Hodgson Ian | Chief Operating Officer | Mar 13, 2025 | OTHER | 3,333 | $3.81 | $12.7K | Form 4 |
| Smethurst Dominic | Chief Medical Officer | Mar 6, 2025 | SELL | 6,393 | $6.78 | $43.3K | Form 4 |
| Moran Sean F. | Chief Financial Officer | Feb 14, 2025 | SELL | 2,792 | $8.76 | $24.4K | Form 4 |
| Cohen Yuval | director, officer: Chief Executive Officer | Feb 14, 2025 | SELL | 7,134 | $8.76 | $62.5K | Form 4 |
| Smethurst Dominic | Chief Medical Officer | Jan 31, 2025 | AWARD | 91,200 | $9.79 | $892.8K | Form 4 |
| Smethurst Dominic | Chief Medical Officer | Jan 31, 2025 | AWARD | 27,200 | — | — | Form 4 |
| Moran Sean F. | Chief Financial Officer | Jan 31, 2025 | AWARD | 92,500 | $9.79 | $905.6K | Form 4 |
| Moran Sean F. | Chief Financial Officer | Jan 31, 2025 | AWARD | 27,500 | — | — | Form 4 |
| Cohen Yuval | director, officer: Chief Executive Officer | Jan 31, 2025 | AWARD | 228,800 | $9.79 | $2.2M | Form 4 |
| Cohen Yuval | director, officer: Chief Executive Officer | Jan 31, 2025 | AWARD | 68,100 | — | — | Form 4 |
| Cormorant Asset Management, LP | 10 percent owner | Sep 20, 2024 | BUY | 25,769 | $22.23 | $572.8K | Form 4 |
| Cormorant Asset Management, LP | 10 percent owner | Sep 20, 2024 | BUY | 47,564 | $21.47 | $1.0M | Form 4 |
| Cormorant Asset Management, LP | 10 percent owner | Sep 20, 2024 | BUY | 139,551 | $20.42 | $2.8M | Form 4 |
| Cormorant Asset Management, LP | 10 percent owner | Sep 20, 2024 | BUY | 66,088 | $19.61 | $1.3M | Form 4 |
| Cormorant Asset Management, LP | 10 percent owner | Sep 20, 2024 | BUY | 25,943 | $18.36 | $476.3K | Form 4 |
| Cormorant Asset Management, LP | 10 percent owner | Sep 20, 2024 | BUY | 45,085 | $17.48 | $787.9K | Form 4 |
| Kung Winston | director | Aug 16, 2024 | AWARD | 5,566 | $53.52 | $297.9K | Form 4 |
| Kung Winston | director | Aug 16, 2024 | AWARD | 5,566 | — | — | Form 4 |
| Kung Winston | Aug 16, 2024 | OTHER | 0 | — | — | Form 4 | |
| Moran Sean F. | Chief Financial Officer | Jun 14, 2024 | OPTION EX. | 7,788 | $4.26 | $33.2K | Form 4 |
| Moran Sean F. | Chief Financial Officer | Jun 17, 2024 | OPTION EX. | 6,730 | $14.10 | $94.9K | Form 4 |
| Moran Sean F. | Chief Financial Officer | Jun 18, 2024 | OPTION EX. | 1,958 | $30.00 | $58.7K | Form 4 |
| Moran Sean F. | Chief Financial Officer | Jun 14, 2024 | OPTION EX. | 1,567 | $30.00 | $47.0K | Form 4 |
| Moran Sean F. | Chief Financial Officer | Jun 17, 2024 | SELL | 6,730 | $46.77 | $314.8K | Form 4 |
| Moran Sean F. | Chief Financial Officer | Jun 18, 2024 | SELL | 1,958 | $42.12 | $82.5K | Form 4 |